A program to generate profits from the diagnostics and reagents, testing and cosmetics-related businesses, support research and development with those proceeds, and achieve profitability on a consolidated basis. It concerns profitability for consolidated results as a whole and is not limited to operating income, ordinary income or net income attributable to owners of the parent.